These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 15182450)
1. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5]. Xu XN; Li ZJ; Li YP Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450 [TBL] [Abstract][Full Text] [Related]
2. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5). Tyler JW; Spears H; Nelson R J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577 [TBL] [Abstract][Full Text] [Related]
3. Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms. Opal SM; Palardy JE; Chen WH; Parejo NA; Bhattacharjee AK; Cross AS J Infect Dis; 2005 Dec; 192(12):2074-80. PubMed ID: 16288370 [TBL] [Abstract][Full Text] [Related]
4. Antiserum treatment of gram-negative bacteremia. Braude AI; Ziegler EJ; McCutchan JA Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528 [TBL] [Abstract][Full Text] [Related]
5. Effect of changes in number of doses and anatomic location for administration of an Escherichia coli bacterin on serum IgG1 and IgG2 concentrations in dairy cows. Erskine RJ; Brockett AR; Beeching ND; Hull RW; Bartlett PC Am J Vet Res; 2010 Jan; 71(1):120-4. PubMed ID: 20043791 [TBL] [Abstract][Full Text] [Related]
7. Treatment of gram-negative bacteremia with antiserum to core glycolipid. I. The experimental basis of immunity to endotoxin. Ziegler EJ; McCutchan JA; Braude AI Eur J Cancer (1965); 1979; 15 Suppl():71-6. PubMed ID: 397063 [No Abstract] [Full Text] [Related]
8. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257 [TBL] [Abstract][Full Text] [Related]
9. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum. Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628 [TBL] [Abstract][Full Text] [Related]
10. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia. McCutchan JA; Wolf JL; Ziegler EJ; Braude AI Schweiz Med Wochenschr Suppl; 1983; 14():40-5. PubMed ID: 6361990 [TBL] [Abstract][Full Text] [Related]
11. Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis. Cross AS; Opal S; Cook P; Drabick J; Bhattacharjee A Vaccine; 2004 Feb; 22(7):812-7. PubMed ID: 15040932 [TBL] [Abstract][Full Text] [Related]
12. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067 [TBL] [Abstract][Full Text] [Related]
13. Functional role of antibody against "core" glycolipid of Enterobacteriaceae. Young LS; Stevens P; Ingram J J Clin Invest; 1975 Oct; 56(4):850-61. PubMed ID: 1099119 [TBL] [Abstract][Full Text] [Related]
14. Effect on cardiopulmonary changes of gram-negative endotoxemia in sheep after type-specific, cross-reactive, and nonspecific immune stimulation. Girotti MJ; Moon B; Patterson GA; Hong K; Todd TR Circ Shock; 1986; 18(3):171-8. PubMed ID: 3516436 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of gram-negative bacterial sepsis: enhanced survival in a guinea pig model by use of rabbit antiserum to Escherichia coli J5. Dunn DL; Ferguson RM Surgery; 1982 Aug; 92(2):212-9. PubMed ID: 7048594 [TBL] [Abstract][Full Text] [Related]
16. Development of an anti-endotoxin vaccine for sepsis. Cross AS Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272 [TBL] [Abstract][Full Text] [Related]
17. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins. Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of antibodies against gram-negative core antigens in rabbits, using an Escherichia coli J5 antigen-capture enzyme-linked immunosorbent assay. Ruble RP; Cullor JS; Brooks DL Am J Vet Res; 1999 Apr; 60(4):501-6. PubMed ID: 10211696 [TBL] [Abstract][Full Text] [Related]
19. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708 [TBL] [Abstract][Full Text] [Related]
20. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Baumgartner JD; Glauser MP; McCutchan JA; Ziegler EJ; van Melle G; Klauber MR; Vogt M; Muehlen E; Luethy R; Chiolero R Lancet; 1985 Jul; 2(8446):59-63. PubMed ID: 2861523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]